临床和实验室表现以及低VWF患者的潜在机制
Omid Seidizadeh1, Alessandro Ciavarella1, Luciano Baronciani2
1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Thrombosis and haemostasis
|October 6, 2023
概括
低·维勒布兰德因子 (VWF) 是由减少VWF合成/分泌和增加VWF清除引起的. 低VWF患者经历显著出血,但同时出现的静血缺陷不会加重症状.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 低·维勒布兰德因子 (VWF) 定义为血水平在30-50 IU/dL之间.
- 导致低VWF的潜在机制尚不清楚.
- 本研究研究了低VWF的临床表现,实验室发现和分子机制.
研究的目的:
- 为了确定低VWF的临床表现.
- 为了确定与低VWF相关的实验室表型.
- 阐明导致VWF水平降低的机制.
主要方法:
- 分析了250名低VWF患者的队列.
- 国际血栓和血液静止学会出血评估工具 (ISTH-BAT) 评估了出血症状.
- 使用VWF propeptide (VWFpp) 试验,FVIII:C/VWF:Ag和VWFpp/VWF:Ag的比率来评估VWF的合成和清除.
主要成果:
- 在35%的儿童,47%的男性和49%的女性中报告了异常出血.
- 在患者队列中观察到减少的VWF合成/分泌.
- 在33%的患者中发现了增强的VWF清除.
- 36%的患者同时存在血静缺陷,但不影响出血严重程度.
结论:
- 减少VWF合成/分泌和增强VWF清除是低VWF背后的关键机制.
- 低VWF患者表现出显著的出血症状.
- 额外的静血缺陷的存在不会加剧低VWF的个体的出血.
相关概念视频
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
13
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
13
Disorders of Hemostasis
973
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
973
Anticoagulant Drugs: Low-Molecular-Weight Heparins
729
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
729
Formation of the Platelet Plug
6.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
Endocarditis II: Clinical Features of Infective Endocarditis
11
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
11
Extrinsic and Intrinsic Pathways of Hemostasis
8.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.1K


